|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/13 | |
| A61K 31/496 | |||
| A61P 25/28 | |||
| A61P 25/16 | |||
| A61P 25/18 |
| (11) | Patento numeris | 3458040 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16766623.9 |
| Europos patento paraiškos padavimo data | 2016-08-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2016/054674 |
| Data | 2016-08-03 |
| (87) | Numeris | WO 2017/199072 |
| Data | 2017-11-23 |
| (30) | Numeris | Data | Šalis |
| 201641017203 | 2016-05-18 | IN |
| (72) |
NIROGI, Ramakrishna, IN
SHINDE, Anil Karbhari, IN
JAYARAJAN, Pradeep, IN
BHYRAPUNENI, Gopinadh, IN
KAMBHAMPATI, Ramasastri, IN
JASTI, Venkateswarlu, IN
|
| (73) |
Suven Life Sciences Limited,
5th Floor Serene Chambers Road No. 5 Off Avenue 7 Banjara Hills, Hyderabad, Telangana 500034,
IN
|
| (54) | COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS WITH NMDA RECEPTOR ANTAGONIST |
| COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS WITH NMDA RECEPTOR ANTAGONIST |